Finance

Lists
Why is 6990 up 3,10%?
Dive Deeper
6990:HKG
Sichuan Kelun-Biotech Biophrmctcl Co Ltd
HK$452,00
+3,10%
(+13,60) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6990...
Open
HK$449,80
High
HK$470,20
Low
HK$449,00
Mkt. cap
108,04 mjd
Avg. vol.
528,16 k
Volume
909,27 k
P/E ratio
594,84
52-wk high
HK$562,50
52-wk low
HK$339,60
EPS
HK$0,76
Shares outstanding
176,82 m
No. of employees
2 k
Open
HK$449,80
High
HK$470,20
Low
HK$449,00
Mkt. cap
108,04 mjd
Avg. vol.
528,16 k
Volume
909,27 k
P/E ratio
594,84
52-wk high
HK$562,50
52-wk low
HK$339,60
EPS
HK$0,76
Shares outstanding
176,82 m
No. of employees
2 k
News stories
From web sources and news partners
About Sichuan Kelun-Biotech Biophrmctcl Co Ltd
CEO-
Employees2,3 k
Founded2016
Headquarters-
Sector-
Websitekelun-biotech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
553,74 m
553,74 m
489,17 m
489,17 m
Cost of goods sold
144,34 m
144,34 m
120,72 m
120,72 m
Cost of revenue
144,34 m
144,34 m
120,72 m
120,72 m
Research and development expenses
354,07 m
354,07 m
384,22 m
384,22 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
200,60 m
200,60 m
235,25 m
235,25 m
Operating expense
520,88 m
520,88 m
259,04 m
259,04 m
Total operating expenses
665,23 m
665,23 m
379,76 m
379,76 m
Operating income
-111,49 m
-111,49 m
109,41 m
109,41 m
Other non operating income
-
-
-
-
EBT including unusual items
-90,11 m
-90,11 m
123,98 m
123,98 m
EBT excluding unusual items
-109,96 m
-109,96 m
116,44 m
116,44 m
Income tax expense
28,29 m
28,29 m
-70,03 m
-70,03 m
Effective tax rate
-31,39%
-31,39%
-56,48%
-56,48%
Other operating expenses
-33,78 m
-33,78 m
-360,43 m
-360,43 m
Net income
-118,40 m
-118,40 m
194,00 m
194,00 m
Net profit margin
-21,38%
-21,38%
39,66%
39,66%
Earnings per share
-
-
-
-
Interest and investment income
25,42 m
25,42 m
9,80 m
9,80 m
Interest expense
-1,57 m
-1,57 m
-1,04 m
-1,04 m
Net interest expenses
23,85 m
23,85 m
8,76 m
8,76 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-97,28 m
-97,28 m
126,87 m
126,87 m
Gain or loss from assets sale
61,50 k
61,50 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme